Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function in Sars-cov2 Associated Myocardial Injury With Heightened Inflammation (canakinumab in Covid-19 Cardiac Injury): Results From the Randomized Three C Study

Cremer, P. C.; Sheng, C.; Sahoo, D.; Dugar, S.; Aguillon-Prada, R.; Hernandez-Montfort, J.; Wolinsky, D.; Wang, T.; Abou Hassan, O.; Brennan, D.; Culver, D.; Rajendram, P.; Duggal, A.; Lincoff, A. M.; Nissen, S. E.; Menon, V.

Cremer, P. C.; Sheng, C.; Sahoo, D.; Dugar, S.; Aguillon-Prada, R.; Hernandez-Montfort, J.; Wolinsky, D.; Wang, T.; Abou Hassan, O.; Brennan, D.; Culver, D.; Rajendram, P.; Duggal, A.; Lincoff, A. M.; Nissen, S. E.; Menon, V..

Circulation ; 142(24):E478-E479, 2020.

Article in English | Web of Science | ID: covidwho-1008347

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies / Randomized controlled trials Language: English Journal: Circulation Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML